Ken Getz is the Director and a professor at the Tufts Center for the Study of Drug Development, Tufts University School of Medicine, where he conducts grant-funded research on pharmaceutical R&D management and execution; protocol design optimization, contract service provider and investigative site management, e-clinical technology and data usage and patient engagement. He is the chairman of CISCRP – a nonprofit organization that he founded to educate and raise public and patient awareness of the clinical research enterprise. A well-known speaker at conferences, symposia, universities, investor meetings and corporations, Ken has published extensively in peer-review journals, books and in the trade press and writes a bi-monthly column nominated for a Neal Award in Applied Clinical Trials. He holds a number of board appointments in the private and public sectors and serves on the editorial boards of Pharmaceutical Medicine and Therapeutic Innovation and Regulatory Science. Ken received an MBA from the J.L. Kellogg Graduate School of Management at Northwestern University and a bachelor’s degree, Phi Beta Kappa, from Brandeis University. He is the founder of CenterWatch, a leading publisher in the clinical trials industry, and one of several businesses that he has created and sold.

Casey Orvin currently serves as Senior VP of Pharmaceutical Relationships for StudyKIK, a full- service patient recruitment and retention technology company, and also as Honorary President of the Society for Clinical Research Sites (SCRS), a global organization representing nearly 10,000 clinical research sites in 47 countries within the pharmaceutical industry. Orvin began his career leading a large pharmaceutical research site network, Research Solutions. In 2007, he was recruited to join Clinical Research Advantage/Radiant as Executive Vice President of Business Development and successfully led a network of over 75 research sites conducting clinical trials for pharmaceuticals, vaccines, and medical devices. Under Orvin’s leadership, several crucial partnerships were formed with major pharmaceutical companies which fueled the company’s rapid growth both geographically and within the medical community. Orvin facilitated the acquisition of two competitors securing the company’s spot as the largest clinical research site network in the US. In 2015, Orvin and the executive team at Radiant merged with the largest site network in the world, Synexus. Under Orvin’s leadership, Synexus continued to expand to 215 global clinical sites in 4 continents and over 15 countries. Orvin is passionate about representing the site voice within the industry while ensuring every research patient’s journey is a positive one.
As a thought-leader in the industry, Orvin is regularly sought after as a keynote speaker and panelist and is often quoted by the leading publications covering the clinical research landscape. In 2020, Orvin was recognized in PharmaVoice as one of the 100 Most Inspiring People in the industry.